Trial Profile
Effect of rivaroxaban for anti-atherosclerotic response in atrial fibrillation patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Aug 2013
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Embolism and thrombosis; Stroke
- Focus Pharmacodynamics
- 18 Aug 2013 New trial record